FDA Inspection 954571 — Sucampo Pharma, LLC

Sucampo Pharma, LLC — FEI 3009036781

The FDA completed an inspection of Sucampo Pharma, LLC on Dec 16, 2015 in Kobe. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 16, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kobe (Japan)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
242021 CFR 211.198(a)Quality Control Review

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.